Trial for Treatment Refractory Trigeminal Neuralgia
Status:
Recruiting
Trial end date:
2021-12-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for
subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater
reduction in the average Numeric Pain Rating Scale between the two-week treatment phases.